larimar
therapeutics
present
oppenheimer
fall
healthcare
life
sciences
medtech
summit
bala
cynwyd
globe
newswire
larimar
therapeutics
nasdaq
lrmr
biotechnology
company
focused
developing
treatments
complex
rare
diseases
today
announced
carole
md
president
chief
executive
officer
virtually
present
oppenheimer
fall
healthcare
life
sciences
medtech
summit
monday
september
edt
larimar
therapeutics
larimar
therapeutics
nasdaq
lrmr
biotechnology
company
focused
developing
treatments
complex
rare
diseases
company
lead
compound
currently
evaluated
phase
clinical
program
potential
treatment
friedreich
ataxia
rare
progressive
genetic
disease
larimar
also
plans
use
intracellular
delivery
platform
design
fusion
proteins
target
additional
rare
diseases
characterized
deficiencies
intracellular
bioactive
compounds
information
please
visit
https
investor
contact
mike
celano
larimar
therapeutics
mcelano
media
contact
gina
cestari
degrees
gcestari
